Research progress on Chinese materia medica in treatment of acute cerebral infarction based on clinical pharmacology
10.7501/j.issn.0253-2670.2015.14.024
- Author:
Jiang-Wei SHI
1
Author Information
1. The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
- Publication Type:Journal Article
- Keywords:
Acute cerebral infarction;
Biological markers;
Chinese materia medica injections;
Clinical pharmacology;
Peripheral blood
- From:
Chinese Traditional and Herbal Drugs
2015;46(14):2160-2166
- CountryChina
- Language:Chinese
-
Abstract:
Stroke is the second cause of human death, while except the blood vessels recanalization, there is no effective drugs supported by evidence-based medicine. At home and abroad in recent years, a biological marker in peripheral blood after acute cerebral infarction attracted a lot of attention. This article explained the clinical pharmacological indexes closely related to the prognosis of acute cerebral infarction and clinical evaluation of Chinese materia medica (CMM) in treatment of acute cerebral infarction from four perspectives such as the injury of brain tissue, inflammation, blood coagulation/thrombosis, and vascular regeneration, in order to further explain the mechanism of action of complex components in CMM and to provide references for the research and development of CMM injection in treatment of acute cerebral infarction big varieties to provide meaningful reference.
